|
Market Cap (17-May) $266,989,456 (489th) |
Close (30-Jun) $5.19 |
Volume (30-Jun) 686,116 |
Shortsold (5-May) 216,918 (0.32%) (348th) |
|
52w High $4.52 |
52w Low $2.00 |
P/E 6.39 |
EPS -0.68 |
AVH released this announcement to the ASX on 11 January 2022, 8:27. The announcement is marked as price sensitive, and is 2 page(s) in length and 215.82kb in size.
You can view all announcements from AVH and see how they appear on a price chart on the announcements page.
At the date of this announcement, AVH was 3.080% short sold according to ASIC data. It was ranked the 56th most shorted stock on the ASX. It remains ranked 348th as of the latest reported data (05 May 2025).
| Other Recent Announcements from AVH | |
|---|---|
| Notice under section 708A(5)(e) of the Corporations Act | 30 June 2023, 12:01 |
| Notification regarding unquoted securities - AVH | 30 June 2023, 11:56 |
| AVITA Medical Submits FDA PMA Supplement for RECELL GO | 30 June 2023, 8:38 |
| AVITA Medical Announces Preliminary Unaudited Results | 11 January 2022, 8:27 |
| Statement of CDIs on issue - AVH | 7 January 2022, 17:08 |
| AVITA Medical Completes Enrollment in Pivotal Trial | 7 January 2022, 9:15 |
| AVITA Medical Establishes Proof of Concept for Gene Therapy | 7 January 2022, 8:22 |
You must be logged in to post a reply.
